v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (21,325) $ (7,659)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,167 888
Stock-based compensation 1,467 619
Accretion and amortization of premiums and discounts on investments, net   (208)
Loss on remeasurement of convertible notes 8,594  
Convertible note issuance costs included in net income 361  
Unrealized foreign exchange loss (gain) 165 (134)
Non-cash operating lease costs 461 465
Amortization of debt issuance costs 67 42
Change in fair value of warrant liabilities 84 (19)
Changes in assets and liabilities:    
Accounts receivable (6,854) (533)
Inventory (1,265) (2,357)
Contract assets   282
Net investment in sales-type lease   86
Prepaid expenses and other current assets (1,960) 191
Other noncurrent assets (327) 182
Accounts payable 1,339 578
Operating lease liabilities (1,087) (463)
Accrued expenses and other liabilities (1,234) (5,028)
Net cash used in operating activities (20,347) (13,068)
Cash flows from investing activities    
Maturities of short-term investments   18,000
Purchases of property and equipment (600) (554)
Capitalized software development costs (178) (428)
Net cash (used in) provided by investing activities (778) 17,018
Cash flows from financing activities:    
Proceeds from issuance of convertible notes 56,500  
Payment of third-party debt issuance costs (324)  
Proceeds from issuance of common stock upon exercise of stock options 1,803 243
Payment of deferred offering costs (2,218)  
Net cash provided by financing activities 55,761 243
Effect of exchange rate changes on cash and cash equivalents, and restricted cash (52) 133
Net increase in cash, cash equivalents and restricted cash 34,584 4,326
Cash, cash equivalents and restricted cash at beginning of period 34,909 31,677
Cash, cash equivalents and restricted cash at end of period 69,493 36,003
Supplemental disclosure of cash-flow information:    
Cash paid for interest 156 3
Noncash investing and financing items:    
Vesting of early exercised stock options 102 7
Equipment transferred to inventory 214 169
Deferred offering costs included in accrued liabilities 2,090  
Property and equipment included in accounts payable and accrued liabilities $ 583 $ 457